SANUWAVE Health, Inc. is a company dedicated to the research, development, and commercialization of non-invasive, high-energy acoustic shockwave technology. Operating both domestically and internationally, the firm applies these shockwaves in regenerative medicine and other therapeutic areas. The underlying principle involves stimulating a biological response within the body, prompting self-healing through the restoration and growth of tissues, musculoskeletal structures, and vascular networks. Its flagship regenerative product is the dermaPACE device, specifically engineered for treating diabetic foot ulcers. The company's diverse range of healthcare solutions and pipeline products are designed to trigger vital biologic signaling and angiogenic responses, such as fostering new vascularization and improving microcirculation, ultimately revitalizing the body's natural healing and regenerative capabilities. SANUWAVE also utilizes its proprietary Pulsed Acoustic Cellular Expression (PACE) technology across various medical fields, including wound healing, orthopedics, plastic/cosmetic applications, and cardiac conditions. Beyond its core shockwave offerings, the company provides the UltraMIST device, a non-contact, non-thermal ultrasound therapy for managing conditions like diabetic foot ulcers, pressure ulcers, venous leg ulcers, deep tissue pressure injuries, and surgical wounds. Additionally, its orthoPACE system addresses tendinopathies and both acute and nonunion fractures. Established in 2005, SANUWAVE Health, Inc. is based in Suwanee, Georgia.
